BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
British-Swedish Pharma Giant AstraZeneca's Alexion Partners with USA's Verge Genomics in a $840 Mn+ Deal September 13, 2023 British-Swedish pharmaceutical major, AstraZeneca, has formed a partnership between its rare disease unit, Alexion, with American biotechnology firm Verge Genomics. The partnership deal is reported to be valued at over $840 million
Page 1 of 1
